<i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

<i>Pneumocystis jirovecii</i> pneumonia (PJP) in immunocompromised patients entails high mortality and requires adequate laboratory diagnosis. We compared the performance of a real time-PCR assay against the immunofluorescence assay (IFA) in the routine of a large microbiology laboratory...

Full description

Bibliographic Details
Main Authors: Cristina Veintimilla, Ana Álvarez-Uría, Pablo Martín-Rabadán, Maricela Valerio, Marina Machado, Belén Padilla, Roberto Alonso, Cristina Diez, Patricia Muñoz, Mercedes Marín
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/9/4/414
_version_ 1797604800969310208
author Cristina Veintimilla
Ana Álvarez-Uría
Pablo Martín-Rabadán
Maricela Valerio
Marina Machado
Belén Padilla
Roberto Alonso
Cristina Diez
Patricia Muñoz
Mercedes Marín
author_facet Cristina Veintimilla
Ana Álvarez-Uría
Pablo Martín-Rabadán
Maricela Valerio
Marina Machado
Belén Padilla
Roberto Alonso
Cristina Diez
Patricia Muñoz
Mercedes Marín
author_sort Cristina Veintimilla
collection DOAJ
description <i>Pneumocystis jirovecii</i> pneumonia (PJP) in immunocompromised patients entails high mortality and requires adequate laboratory diagnosis. We compared the performance of a real time-PCR assay against the immunofluorescence assay (IFA) in the routine of a large microbiology laboratory. Different respiratory samples from HIV and non-HIV-infected patients were included. The retrospective analysis used data from September 2015 to April 2018, which included all samples for which a <i>P. jirovecii</i> test was requested. A total of 299 respiratory samples were tested (bronchoalveolar lavage fluid (<i>n</i> = 181), tracheal aspirate (<i>n</i> = 53) and sputum (<i>n</i> = 65)). Forty-eight (16.1%) patients fulfilled the criteria for PJP. Five positive samples (10%) had only colonization. The PCR test was found to have a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 96%, 98%, 90% and 99%, compared to 27%, 100%, 100% and 87%, for the IFA, respectively. PJ-PCR sensitivity and specificity were >80% and >90% for all tested respiratory samples. Median cycle threshold values in definite PJP cases were 30 versus 37 in colonized cases (<i>p</i> < 0.05). Thus, the PCR assay is a robust and reliable test for the diagnosis PJP in all respiratory sample types. Ct values of ≥36 could help to exclude PJP diagnosis.
first_indexed 2024-03-11T04:51:55Z
format Article
id doaj.art-4c95503f80b04346aea579bf77457c94
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-11T04:51:55Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-4c95503f80b04346aea579bf77457c942023-11-17T19:57:49ZengMDPI AGJournal of Fungi2309-608X2023-03-019441410.3390/jof9040414<i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary CentreCristina Veintimilla0Ana Álvarez-Uría1Pablo Martín-Rabadán2Maricela Valerio3Marina Machado4Belén Padilla5Roberto Alonso6Cristina Diez7Patricia Muñoz8Mercedes Marín9Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, SpainDepartment of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain<i>Pneumocystis jirovecii</i> pneumonia (PJP) in immunocompromised patients entails high mortality and requires adequate laboratory diagnosis. We compared the performance of a real time-PCR assay against the immunofluorescence assay (IFA) in the routine of a large microbiology laboratory. Different respiratory samples from HIV and non-HIV-infected patients were included. The retrospective analysis used data from September 2015 to April 2018, which included all samples for which a <i>P. jirovecii</i> test was requested. A total of 299 respiratory samples were tested (bronchoalveolar lavage fluid (<i>n</i> = 181), tracheal aspirate (<i>n</i> = 53) and sputum (<i>n</i> = 65)). Forty-eight (16.1%) patients fulfilled the criteria for PJP. Five positive samples (10%) had only colonization. The PCR test was found to have a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 96%, 98%, 90% and 99%, compared to 27%, 100%, 100% and 87%, for the IFA, respectively. PJ-PCR sensitivity and specificity were >80% and >90% for all tested respiratory samples. Median cycle threshold values in definite PJP cases were 30 versus 37 in colonized cases (<i>p</i> < 0.05). Thus, the PCR assay is a robust and reliable test for the diagnosis PJP in all respiratory sample types. Ct values of ≥36 could help to exclude PJP diagnosis.https://www.mdpi.com/2309-608X/9/4/414<i>Pneumocystis jirovecii</i> pneumoniaindirect immunofluorescencestainingpolymerase chain reaction (PCR)diagnostic accuracyimmunocompromised host
spellingShingle Cristina Veintimilla
Ana Álvarez-Uría
Pablo Martín-Rabadán
Maricela Valerio
Marina Machado
Belén Padilla
Roberto Alonso
Cristina Diez
Patricia Muñoz
Mercedes Marín
<i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
Journal of Fungi
<i>Pneumocystis jirovecii</i> pneumonia
indirect immunofluorescence
staining
polymerase chain reaction (PCR)
diagnostic accuracy
immunocompromised host
title <i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
title_full <i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
title_fullStr <i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
title_full_unstemmed <i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
title_short <i>Pneumocystis jirovecii</i> Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre
title_sort i pneumocystis jirovecii i pneumonia diagnostic approach real life experience in a tertiary centre
topic <i>Pneumocystis jirovecii</i> pneumonia
indirect immunofluorescence
staining
polymerase chain reaction (PCR)
diagnostic accuracy
immunocompromised host
url https://www.mdpi.com/2309-608X/9/4/414
work_keys_str_mv AT cristinaveintimilla ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT anaalvarezuria ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT pablomartinrabadan ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT maricelavalerio ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT marinamachado ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT belenpadilla ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT robertoalonso ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT cristinadiez ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT patriciamunoz ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre
AT mercedesmarin ipneumocystisjiroveciiipneumoniadiagnosticapproachreallifeexperienceinatertiarycentre